Compare ZLAB & RVLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZLAB | RVLV |
|---|---|---|
| Founded | 2013 | 2003 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | 2017 | 2018 |
| Metric | ZLAB | RVLV |
|---|---|---|
| Price | $23.14 | $24.94 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 12 |
| Target Price | ★ $49.60 | $29.73 |
| AVG Volume (30 Days) | ★ 700.3K | 665.2K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.46 | 24.64 |
| EPS | N/A | ★ 0.86 |
| Revenue | $460,156,000.00 | ★ $1,225,682,000.00 |
| Revenue This Year | $9.75 | $10.96 |
| Revenue Next Year | $26.03 | $8.01 |
| P/E Ratio | ★ N/A | $29.16 |
| Revenue Growth | ★ 15.33 | 8.48 |
| 52 Week Low | $15.96 | $16.80 |
| 52 Week High | $44.34 | $31.68 |
| Indicator | ZLAB | RVLV |
|---|---|---|
| Relative Strength Index (RSI) | 73.24 | 56.52 |
| Support Level | $16.88 | $20.56 |
| Resistance Level | $27.23 | $26.65 |
| Average True Range (ATR) | 0.75 | 1.00 |
| MACD | 0.36 | 0.39 |
| Stochastic Oscillator | 98.15 | 75.27 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
Revolve Group Inc is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2024 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the U.S, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 18% of sales from private-label offerings, while focusing on building an inventory of distinctive products from emerging fashion brands with less than $10 million in annual sales.